Imprint Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.39K Buy
63
+18
+40% +$2.53K 0.03% 146
2026
Q2
$5.68K Hold
45
– – 0.02% 165
2026
Q1
$6.27K Hold
45
– – 0.03% 152
2025
Q4
$5.52K Sell
45
-97
-68% -$11.8K 0.03% 185
2025
Q3
$15.8K Buy
+142
New +$16.1K 0.05% 148
2024
Q1
$266K Buy
3,648
+301
+9% +$23.1K 0.06% 246
2023
Q4
$271K Buy
3,347
+576
+21% +$44.8K 0.22% 128
2023
Q3
$208K Buy
+2,771
New +$213K 0.18% 141

Other funds holding GILD

Imprint Wealth's GILD Position: Q3 2026 in Review

Imprint Wealth increased its Gilead Sciences (GILD) stake by 40% in Q3 2026, buying an estimated $2.53K and bringing the position to 63 shares worth $9.39K. The position accounts for 0.03% of the portfolio, ranked #146.

Imprint Wealth first reported a position in GILD in Q3 2023 and has held it in 8 quarters since. The position peaked at $271K in Q4 2023. 2,341 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Imprint Wealth held 63 shares of Gilead Sciences worth $9.39K as of Q3 2026.
  • Imprint Wealth bought 18 Gilead Sciences shares in Q3 2026, an estimated $2.53K.
  • Gilead Sciences made up 0.03% of Imprint Wealth's portfolio in Q3 2026, its #146 holding.
  • Imprint Wealth first reported a position in Gilead Sciences in Q3 2023 and has held it in 8 quarters since.
  • Imprint Wealth's Gilead Sciences position peaked at $271K in Q4 2023.
  • 2,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Imprint Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.